[Polychemotherapy of bronchopulmonary cancers (apropos of 21 cases)].
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy*; D008466:Mechlorethamine / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D014747:Vinblastine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D001389:Azirines; D006834:Hydrazines; D008466:Mechlorethamine; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate
Polychimiothérapie des cancers bronchopulmonaires (a propos de 21 cas)